REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2016

Dec 19, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REGENERON PHARMACEUTICALS INC (REGN)
CIK: 0000872589
Period of Report: 2016-12-16

Reporting Person: Powchik Peter (SVP Clinical Development & Reg)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-05-16	Common Stock	G	2459	$0.0	Disposed	2459	Indirect
2016-05-16	Common Stock	G	2459	$0.0	Disposed	0	Indirect
2016-05-16	Common Stock	G	2459	$0.0	Acquired	2459	Indirect
2016-05-16	Common Stock	G	2459	$0.0	Acquired	2459	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-12-16	Non-Qualified Stock Option (right to buy)	$381.92	A	5000	Acquired	2026-12-16	Common Stock (5000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	25714	Direct
Common Stock	1674	Indirect

Footnotes

F1: By a trust for the benefit of the reporting person's son of which the reporting person's spouse is trustee.

F2: By a trust for the benefit of the reporting person's daughter of which the reporting person's spouse is trustee.

F3: The stock option award vests in full one year after the date of grant.